The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox
Abstract
Fragile X syndrome results from mutations in a (CGG)n repeat found in the coding sequence of the FMR-1 gene. Analysis of length variation in this region in normal individuals shows a range of allele sizes varying from a low of 6 to a high of 54 repeats. Premutations showing no phenotypic effect in fragile X families range in size from 52 to over 200 repeats. All alleles with greater than 52 repeats, including those identified in a normal family, are meiotically unstable with a mutation frequency of one, while 75 meioses of alleles of 46 repeats and below have shown no mutation. Premutation alleles are also mitotically unstable as mosaicism is observed. The risk of expansion during oogenesis to the full mutation associated with mental retardation increases with the number of repeats, and this variation in risk accounts for the Sherman paradox.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FXS is caused by mutations in the FMR1 gene, which is located on the X chromosome and whose locus at Xq27.3 coincides with the folate-sensitive fragile site (4, 5).”
From Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics (2012) · cites this paper as [5]
Citations
Cites
Hypervariable ‘minisatellite’ regions in human DNA
Jeffreys, A. J., Wilson, V., & Thein, S. L. (1985) · Nature · doi:10.1038/314067a0 · Cited by 3,771
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
Self-citationInstability of a 550-Base Pair DNA Segment and Abnormal Methylation in Fragile X Syndrome
Oberlé, I., Rousseau, F., Heitz, D., Kretz, C., Devys, D., Hanauer, A., Boué, J., Bertheas, M. F., & Mandel, J. L. (1991) · Science · doi:10.1126/science.252.5009.1097 · Cited by 1,499
Absence of expression of the FMR-1 gene in fragile X syndrome
Pieretti, M., Zhang, F., Fu, Y.-H., Warren, S. T., Oostra, B. A., Caskey, C. T., & Nelson, D. L. (1991) · Cell · doi:10.1016/0092-8674(91)90125-i · Cited by 1,476
Self-citationDNA typing and genetic mapping with trimeric and tetrameric tandem repeats.
Edwards, A., Civitello, A. B., Hammond, H. A., & Caskey, C. T. (1991) · Europe PMC (PubMed Central) · Cited by 1,147
Self-citationMapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n
Kremer, E., Pritchard, M., Lynch, M., Yu, S., Holman, K., Baker, E., Warren, S., Schlessinger, D., Sutherland, G., & Richards, R. (1991) · Science · doi:10.1126/science.1675488 · Cited by 929
Self-citationFragile X Genotype Characterized by an Unstable Region of DNA
Yu, S., Pritchard, M. A., Kremer, E. J., Lynch, M., Nancarrow, J. K., Baker, E. G., Holman, K., Mulley, J. C., Warren, S. T., Schlessinger, D., et al. (1991) · Science · doi:10.1126/science.252.5009.1179 · Cited by 793
Self-citationJeffreys, A. J., Royle, N. J., Wilson, V., & Wong, Z. Y. H. (1988) · Nature · doi:10.1038/332278a0 · Cited by 759
Stark, G. R., & Wahl, G. M. (1984) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.53.070184.002311 · Cited by 583
Centre d'Etude du polymorphisme humain (CEPH): Collaborative genetic mapping of the human genome
Dausset, J. B., Cann, H. M., Cohen, D., Lathrop, M. G., Lalouel, J.-M., & White, R. L. (1990) · Genomics · doi:10.1016/0888-7543(90)90491-c · Cited by 575
Cited by
Sorted by citations
Items 101–200 of 1,005
Rousseau, F., Heitz, D., Tarleton, J. C., MacPherson, J., Malmgren, H., Dahl, N., Barnicoat, A. J., Mathew, C. G., Mornet, É., & Tejada, I. (1994) · PubMed Central · Cited by 291
van Karnebeek, C., Jansweijer, M. C. E., Leenders, A. G. E., Offringa, M., & Hennekam, R. C. M. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201279 · Cited by 289
On the wrong DNA track: Molecular mechanisms of repeat-mediated genome instability
Khristich, A. N., & Mirkin, S. M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.007678 · Cited by 289
Mouse genetic models for prepulse inhibition: an early review
Geyer, M. A., McIlwain, K. L., & Paylor, R. E. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001159 · Cited by 289
(Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features
Peier, A. M. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.8.1145 · Cited by 285
Receptor-like Genes in the Major Resistance Locus of Lettuce Are Subject to Divergent Selection
Meyers, B. C., Shen, K. A., Rohani, P., Gaut, B. S., & Michelmore, R. W. (1998) · The Plant Cell · doi:10.1105/tpc.10.11.1833 · Cited by 285
Abitbol, M. M., Ménini, C., Delezoide, A., Rhyner, T. A., Vekemans, M. J. J., & Mallet, J. J. (1993) · Nature Genetics · doi:10.1038/ng0693-147 · Cited by 284
Filipovic-Sadic, S., Sah, S., Chen, L., Krosting, J., Sekinger, E. A., Zhang, W., Hagerman, P. J., Stenzel, T. T., Hadd, A. G., Latham, G. J., et al. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.136101 · Cited by 280
Wan, L., Dockendorff, T. C., Jongens, T. A., & Dreyfuss, G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.22.8536-8547.2000 · Cited by 280
Fragile X syndrome: Diagnostic and carrier testing
Sherman, S. L., Pletcher, B. A., & Driscoll, D. A. (2005) · Genetics in Medicine · doi:10.1097/01.gim.0000182468.22666.dd · Cited by 283
Siomi, M. C., Zhang, Y., Siomi, H., & Dreyfuss, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3825 · Cited by 271
Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes
Thornton, C. A., Johnson, K. J., & Moxley, R. T. (1994) · Annals of Neurology · doi:10.1002/ana.410350116 · Cited by 274
Irwin, S. A., Idupulapati, M., Gilbert, M. E., Harris, J. B., Chakravarti, A. B., Rogers, E. J., Crisostomo, R. A., Larsen, B. P., Mehta, A., Alcantara, C. J., et al. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10500 · Cited by 270
Self-citationAshley, C. T., Sutcliffe, J. S., Kunst, C. B., Leiner, H. A., Eichler, E. E., Nelson, D. L., & Warren, S. T. (1993) · Nature Genetics · doi:10.1038/ng0793-244 · Cited by 269
Self-citationUsdin, K. (2008) · Genome Research · doi:10.1101/gr.070409.107 · Cited by 268
Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency
Visser, J. A., Schipper, I., Laven, J. S. E., & Themmen, A. P. N. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.224 · Cited by 268
Sakai, J., Hoshino, A., Takahashi, S., Miura, Y., Ishii, H., Suzuki, H., Kawarabayasi, Y., & Yamamoto, T. T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42151-x · Cited by 268
Willemsen, R. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg114 · Cited by 267
Genetic mapping of a second myotonic dystrophy locus
Ranum, L. P. W., Rasmussen, P. F., Benzow, K. A., Koob, M. D., & Day, J. (1998) · Nature Genetics · doi:10.1038/570 · Cited by 263
Rapid Fragile X Carrier Screening and Prenatal Diagnosis Using a Nonradioactive PCR Test
Brown, W. T. (1993) · JAMA · doi:10.1001/jama.1993.03510130075034 · Cited by 267
Vries, B. B. A. D., Halley, D. J. J., Oostra, B. A., & Niermeijer, M. F. (1998) · Journal of Medical Genetics · doi:10.1136/jmg.35.7.579 · Cited by 262
Self-citationPearson, C. E., & Sinden, R. R. (1996) · Biochemistry · doi:10.1021/bi9601013 · Cited by 258
Genetic Anticipation and Abnormal Gender Ratio at Birth in Familial Primary Pulmonary Hypertension
Loyd, J. E., Butler, M. G., Foroud, T., Conneally, P. M., Phillips, J. A., & Newman, J. H. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.1.7599869 · Cited by 253
Epilepsy and EEG Findings in Males with Fragile X Syndrome
Musumeci, S. A., Hagerman, R. J., Ferri, R., Bosco, P., Bernardina, B. D., Tassinari, C. A., Sarro, G. D., & Elia, M. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00824.x · Cited by 250
DNA structures, repeat expansions and human hereditary disorders
Mirkin, S. M. (2006) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2006.05.004 · Cited by 246
Goldberg, Y. P., Kremer, B. P. H., Andrew, S. E., Theilmann, J., Graham, R. K., Squitieri, F., Telenius, H., Adam, S., Sajoo, A., Starr, E. M., et al. (1993) · Nature Genetics · doi:10.1038/ng1093-174 · Cited by 246
Wilke, C. M., Hall, B. K., Hoge, A., Paradee, W. J., Smith, D. I., & Glover, T. W. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.2.187 · Cited by 244
De novo expansion of a (CAG)n repeat in sporadic Huntington's disease
Myers, R. H., MacDonald, M. E., Koroshetz, W. J., Duyao, M. P., Ambrose, C. M., Taylor, S. A., Barnes, G., Srinidhi, J., Lin, C. S., Whaley, W. L., et al. (1993) · Nature Genetics · doi:10.1038/ng1093-168 · Cited by 245
Usdin, K., & Woodford, K. J. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.20.4202 · Cited by 241
Simple repetitive DNA sequences from primates: Compilation and analysis
Jurka, J., & Pethiyagoda, C. L. (1995) · Journal of Molecular Evolution · doi:10.1007/bf00167107 · Cited by 237
FXR1, an autosomal homolog of the fragile X mental retardation gene.
Siomi, M. C., Siomi, H., Sauer, W. H., Srinivasan, S., Nussbaum, R. L., & Dreyfuss, G. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07237.x · Cited by 241
Preferential Nucleosome Assembly at DNA Triplet Repeats from the Myotonic Dystrophy Gene
Wang, Y.-H., Amirhaeri, S., Kang, S., Wells, R. D., & Griffith, J. D. (1994) · Science · doi:10.1126/science.8036515 · Cited by 236
Lavedan, C. N., Hofmann-Radvanyi, H., Shelbourne, P., Rabès, J., Duros, C., Savoy, D., Dehaupas, I., Luce, S., Johnson, K. J., & Junien, C. (1993) · Europe PMC (PubMed Central) · Cited by 235
Association of fragile X syndrome with delayed replication of the FMR1 gene
Hansen, R. S., Canfield, T. K., Lamb, M. M., Gartler, S. M., & Laird, C. D. (1993) · Cell · doi:10.1016/0092-8674(93)90365-w · Cited by 234
Hessl, D. R., Tassone, F., Loesch, D. Z., Berry‐Kravis, E., Leehey, M. A., Gane, L. W., Barbato, I. T., Rice, C. D., Gould, E. L., Hall, D. A., et al. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30241 · Cited by 233
Maddalena, A., Richards, C. S., McGinniss, M. J., Brothman, A. R., Desnick, R. J., Grier, R. E., Hirsch, B. A., Jacky, P. B., McDowell, G. A., Popovich, B. W., et al. (2001) · Genetics in Medicine · doi:10.1097/00125817-200105000-00010 · Cited by 232
Translational animal models of autism and neurodevelopmental disorders
Crawley, J. N. (2012) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2012.14.3/jcrawley · Cited by 236
Transcription-Associated R-Loop Formation across the Human FMR1 CGG-Repeat Region
Loomis, E. W., Sanz, L. A., Chedin, F. L., & Hagerman, P. J. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004294 · Cited by 237
Anticipation in bipolar affective disorder.
McInnis, M. G., McMahon, F. J., Chase, G. A., Simpson, S. G., Ross, C. A., & DePaulo, J. R. (1993) · PubMed · Cited by 230
Fragile-X Carrier Screening and the Prevalence of Premutation and Full-Mutation Carriers in Israel
Toledano‐Alhadef, H., Basel‐Vanagaite, L., Magal, N., Davidov, B., Ehrlich, S., Drasinover, V., Taub, E., Halpern, G. J., Ginott, N., & Shohat, M. (2001) · The American Journal of Human Genetics · doi:10.1086/321974 · Cited by 228
Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population.
Snow, K., Doud, L. K., Hagerman, R. J., Pergolizzi, R. G., Erster, S. H., & Thibodeau, S. N. (1993) · PubMed · Cited by 226
Expansions and Contractions in a Tandem Repeat Induced by Double-Strand Break Repair
Pâques, F., Leung, W.-Y., & Haber, J. E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.2045 · Cited by 226
Vries, B. B. A. D., van den Ouweland, A. M. W., Mohkamsing, S., Duivenvoorden, H. J., Mol, E., Gelsema, K., van Rijn, M., Halley, D. J. J., Sandkuijl, L. A., Oostra, B. A., et al. (1997) · The American Journal of Human Genetics · doi:10.1086/515496 · Cited by 227
Self-citationGenetic Testing in Neurodevelopmental Disorders
Savatt, J. M., & Myers, S. M. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.526779 · Cited by 237
Targeted long-read sequencing identifies missing disease-causing variation
Miller, D. E., Sulovari, A., Wang, T., Loucks, H., Hoekzema, K., Munson, K. M., Lewis, A. P., Fuerte, E. P. A., Paschal, C. R., Walsh, T., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.06.006 · Cited by 233
Vandenbergh, D. J., Persico, A. M., & Uhl, G. R. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90165-8 · Cited by 222
Hagerman, R. J., Hull, C. E., Safanda, J. F., Carpenter, I., Staley, L. W., O'Connor, R. A., Seydel, C., Mazzocco, M. M. M., Snow, K., Thibodeau, S. N., et al. (1994) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320510404 · Cited by 222
Self-citationFragile X syndrome without CCG amplification has an FMR1 deletion
Gedeon, Á. K., Baker, E., Robinson, H., Partington, M. W., Gross, B., Manca, A., Korn, B., Poustka, A., Yu, S., Sutherland, G. R., et al. (1992) · Nature Genetics · doi:10.1038/ng0892-341 · Cited by 220
DNA secondary structure: A common and causative factor for expansion in human disease
McMurray, C. T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.1823 · Cited by 219
Rapid evolution of the sex determining locus in Old World mice and rats
Tucker, P. K., & Lundrigan, B. L. (1993) · Nature · doi:10.1038/364715a0 · Cited by 216
Behavioral and neuroanatomical characterization of the Fmr1 knockout mouse
Mineur, Y. S., Sluyter, F., de Wit, S., Oostra, B. A., & Crusio, W. E. (2002) · Hippocampus · doi:10.1002/hipo.10005 · Cited by 216
Self-citationKamath-Loeb, A., Loeb, L., Johansson, E., Burgers, P., & Fry, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100253200 · Cited by 227
A Comprehensive Genetic Linkage Map of the Human Genome
Donis-Keller, H. (1992) · Science · Cited by 210
Mildly impaired water maze performance in maleFmr1 knockout mice
D'Hooge, R., Nagels, G., Franck, F., Bakker, C. E., Reyniers, E., Storm, K., Kooy, R. F., Oostra, B. A., Willems, P. J., & De Deyn, P. P. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00224-2 · Cited by 208
Self-citationMolecular-clinical correlations in males with an expanded FMR1 mutation
Merenstein, S. A., Sobesky, W. E., Taylor, A. K., Riddle, J. E., Tran, H. X., & Hagerman, R. J. (1996) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19960809)64:2 · Cited by 213
Origin of the expansion mutation in myotonic dystrophy
Imbert, G., Kretz, C., Johnson, K. J., & Mandel, J. (1993) · Nature Genetics · doi:10.1038/ng0593-72 · Cited by 208
Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome
Hoeffer, C. A., Sanchez, E., Hagerman, R. J., Mu, Y., Nguyen, D. V., Wong, H., Whelan, A. M., Zukin, R. S., Klann, E., & Tassone, F. (2012) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2012.00768.x · Cited by 198
Mental status of females with an FMR1 gene full mutation.
de Vries, B. B., Wiegers, A. M., Smits, A., Mohkamsing, S., Duivenvoorden, H. J., Fryns, J. P., Curfs, L., Halley, D. J. J., Oostra, B. A., van den Ouweland, A. M., et al. (1996) · PubMed Central · Cited by 206
Self-citationLukusa-Tshilobo, P., & Fryns, J. P. (2007) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2007.10.005 · Cited by 207
Myotonic dystrophy: Emerging mechanisms for DM1 and DM2
Cho, D. H., & Tapscott, S. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.05.013 · Cited by 203
Fernandez-Carvajal, I., Walichiewicz, P., Xiaosen, X., Pan, R., Hagerman, P. J., & Tassone, F. (2009) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2009.080173 · Cited by 204
Glutamine repeats and inherited neurodegenerative diseases: molecular aspects
Perutz, M. F. (1996) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(96)80016-9 · Cited by 204
The Unstable Repeats—Three Evolving Faces of Neurological Disease
Nelson, D. L., Orr, H. T., & Warren, S. T. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.022 · Cited by 207
Self-citationIonotropic Glutamate Receptors & CNS Disorders
Bowie, D. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708784083821 · Cited by 207
Advances in Molecular Analysis of Fragile X Syndrome
Warren, S. T. (1994) · JAMA · doi:10.1001/jama.1994.03510310066040 · Cited by 204
Self-citationNagafuchi, S., Yanagisawa, H., Ohsaki, E., Shirayama, T., Tadokoro, K., Inoue, T., & Yamada, M. (1994) · Nature Genetics · doi:10.1038/ng1094-177 · Cited by 202
Molecular-clinical spectrum of the ATR-X syndrome
Gibbons, R. J., & Higgs, D. R. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(200023)97:3 · Cited by 240
Defining ovarian reserve to better understand ovarian aging
Gleicher, N., Weghofer, A., & Barad, D. H. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-23 · Cited by 207
Histone Modifications Depict an Aberrantly Heterochromatinized FMR1 Gene in Fragile X Syndrome
Coffee, B. W., Zhang, F. P., Ceman, S., Warren, S. T., & Reines, D. (2002) · The American Journal of Human Genetics · doi:10.1086/342931 · Cited by 202
Self-citationElevatedFMR1mRNA in premutation carriers is due to increased transcription
Tassone, F., Beilina, A. G., Carosi, C., Albertosi, S., Bagni, C., Li, L., Glover-Cutter, K. M., Bentley, D. L., & Hagerman, P. J. (2007) · RNA · doi:10.1261/rna.280807 · Cited by 199
In Vitro Reactivation of the FMR1 Gene Involved in Fragile X Syndrome
Chiurazzi, P., Pomponi, M. G., Willemsen, R., Oostra, B. A., & Neri, G. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.1.109 · Cited by 198
Self-citationMicrosatellite Allelic Homoplasy Due to Variable Flanking Sequences
Grimaldi, M.-C., & Crouau‐Roy, B. (1997) · Journal of Molecular Evolution · doi:10.1007/pl00006151 · Cited by 198
Timchenko, L., Timchenko, N. A., Caskey, C. T., & Roberts, R. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.1.115 · Cited by 198
Self-citationCharacterization of the full fragile X syndrome mutation in fetal gametes
Malter, H. E., Iber, J. C., Willemsen, R., Graaff, E. D., Tarleton, J. C., Leisti, J., Warren, S. T., & Oostra, B. A. (1997) · Nature Genetics · doi:10.1038/ng0297-165 · Cited by 197
Self-citationDynamic alternative DNA structures in biology and disease
Wang, G., & Vasquez, K. M. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-022-00539-9 · Cited by 196
Gametic but not somatic instability of CAG repeat length in Huntington's disease.
MacDonald, M. E., Barnes, G., Srinidhi, J., Duyao, M. P., Ambrose, C. M., Myers, R. H., Jackson, J. G., Conneally, P. M., Young, A. B., & Penney, J. B. (1993) · Journal of Medical Genetics · doi:10.1136/jmg.30.12.982 · Cited by 198
Doyu, M., Sobue, G., Mukai, E., Kachi, T., Yasuda, T., Mitsuma, T., & Takahashi, A. (1992) · Annals of Neurology · doi:10.1002/ana.410320517 · Cited by 193
Immunocytochemical and Biochemical Characterization of FMRP, FXR1P, and FXR2P in the Mouse
Bakker, C. E., de Diego‐Otero, Y., Bontekoe, C. J. M., Raghoe, P., Luteijn, T., Hoogeveen, A. T., Oostra, B. A., & Willemsen, R. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4932 · Cited by 198
Self-citationThe Cognitive Neuroscience of Development
de Haan, M., & Johnson, M. (2005) · Psychology Press eBooks · doi:10.4324/9780203989395 · Cited by 193
Human Models Are Needed for Studying Human Neurodevelopmental Disorders
Zhao, X., & Bhattacharyya, A. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.10.009 · Cited by 192
Trinucleotide repeat expansion in neurological disease
Spada, A. R. L., Paulson, H. L., & Fischbeck, K. H. (1994) · Annals of Neurology · doi:10.1002/ana.410360604 · Cited by 187
Emerging Roles for Ubiquitin and Protein Degradation in Neuronal Function
Yi, J. J., & Ehlers, M. D. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.1.4 · Cited by 224
Entezam, A., Biacsi, R. E., Orrison, B. M., Saha, T., Hoffman, G. E., Grabczyk, E., Nussbaum, R. L., & Usdin, K. (2007) · Gene · doi:10.1016/j.gene.2007.02.026 · Cited by 184
Evidence of founder chromosomes in fragile X syndrome
Richards, R. I., Holman, K. J., Friend, K. L., Kremer, E. J., Hillen, D., Staples, A., Brown, W. T., Goonewardena, P., Tarleton, J. C., Schwartz, C. E., et al. (1992) · Nature Genetics · doi:10.1038/ng0792-257 · Cited by 184
Genes with triplet repeats: candidate mediators of neuropsychiatric disorders
Ross, C. A., McInnis, M. G., Margolis, R. L., & Li, S.-H. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90175-l · Cited by 184
Bretherick, K. L., Fluker, M. R., & Robinson, W. P. (2005) · Human Genetics · doi:10.1007/s00439-005-1326-8 · Cited by 187
Reduced FMR1 mRNA translation efficiency in Fragile X patients with premutations
Primerano, B., Tassone, F., Hagerman, R. J., Hagerman, P. J., Amaldi, F., & Bagni, C. (2002) · RNA · doi:10.1017/s1355838202020642 · Cited by 182
AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome
Yrigollen, C. M., Durbin-Johnson, B., Gane, L., Nelson, D. L., Hagerman, R., Hagerman, P. J., & Tassone, F. (2012) · Genetics in Medicine · doi:10.1038/gim.2012.34 · Cited by 179
Self-citationEvidence of Early Ovarian Aging in Fragile X Premutation Carriers
Welt, C. K., Smith, P. C., & Taylor, A. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0347 · Cited by 181
Genomic imprinting and gene activation in cancer
Feinberg, A. P. (1993) · Nature Genetics · doi:10.1038/ng0693-110 · Cited by 181
Park, C.-Y., Halevy, T., Lee, D. R., Sung, J. J., Lee, J. S., Yanuka, O., Benvenisty, N., & Kim, D.-W. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.084 · Cited by 178
Familial transmission of the FMR1 CGG repeat.
Nolin, S. L., Lewis, F. A., Ye, L., Houck, G. E., Glicksman, A., Limprasert, P., Li, S. Y., Zhong, N., Ashley‐Koch, A. E., Feingold, E., et al. (1996) · PubMed Central · Cited by 178
Rapid antibody test for fragile X syndrome
Willemsen, R., Mohkamsing, S., de Vries, B., van den Ouweland, A., GALJAARD, H., Oostra, B. A., Devys, D., & Mandel, J. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90979-6 · Cited by 177
Self-citationApartis, E., Blancher, A., Meissner, W. G., Guyant‐Maréchal, L., Maltête, D., de Broucker, T., Legrand, A. P., Bouzenada, H., Tran-Thanh, H., Sallansonnet-Froment, M., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318271f7ff · Cited by 178
Lafrenière, R. G., Rochefort, D. L., Chrétien, N., Rommens, J. M., Cochius, J. I., Kälviäinen, R. K., Nousiainen, U., Patry, G., Farrell, K., Söderfeldt, B. A., et al. (1997) · Nature Genetics · doi:10.1038/ng0397-298 · Cited by 175
Wöhrle, D., Hennig, I., Vogel, W., & Steinbach, P. (1993) · Nature Genetics · doi:10.1038/ng0693-140 · Cited by 174
Genomic Instability and Tumor Progression: Mechanistic Considerations
Cheng, K. C., & Loeb, L. A. (1992) · Advances in cancer research · doi:10.1016/s0065-230x(08)60824-6 · Cited by 173
Genotype–phenotype relationship in female carriers of the premutation and full mutation of FMR-1
Franke, P. E., Leboyer, M., Gänsicke, M., Weiffenbach, O., Biancalana, V., Cornillet‐Lefèbvre, P., CROQUETTE, M. F., Froster, U. G., Schwab, S. G., Poustka, F., et al. (1998) · Psychiatry Research · doi:10.1016/s0165-1781(98)00055-9 · Cited by 173
Uniform amplification of a mixture of deoxyribonucleic acids with varying GC content.Preprint
Baskaran, N., Kandpal, R. P., Bhargava, A. K., Glynn, M. W., Bale, A. E., & Weissman, S. M. (1996) · Genome Research · doi:10.1101/gr.6.7.633 · Cited by 171
Tassone, F., Hagerman, R. J., Garcia-Arocena, D., Khandjian, E. W., Greco, C. M., & Hagerman, P. J. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.012518 · Cited by 172
Metadata
- Authors
- Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkert, A. J. M. H., Holden, J. J. A., Fenwick, R. G., Warren, S. T., Oostra, B. A., Nelson, D. L., & Caskey, C. T.
- Affiliations
- Howard Hughes Medical Institute (US)
- Queen's University (CA)
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1991-12
- Volume
- 67
- Issue
- 6
- Pages
- 1047-1058
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2167119720
- Cited by
- 2,080
- References
- 25
- Citations by year
- 2026: 12 · 2025: 23 · 2024: 36 · 2023: 22 · 2022: 31 · 2021: 41 · 2020: 43 · 2019: 37 · 2018: 49 · 2017: 34 · 2016: 65 · 2015: 56 · 2014: 78 · 2013: 68 · 2012: 70
- FWCI
- 58.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Human Genome Research Institute (HG00038)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 20521)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- fragile X syndrome, CGG repeat, FMR1 gene, premutation, repeat expansion, meiotic instability, mitotic instability, mosaicism, repeat length variation, oogenesis, intellectual disability
- MeSH terms
- Alleles, Base Sequence, Exons, Fragile X Syndrome, Genes, Humans, Meiosis, Methylation, Molecular Sequence Data, Mosaicism, Oligodeoxyribonucleotides, Pedigree, Polymorphism, Genetic, Repetitive Sequences, Nucleic Acid, Risk Factors, X Chromosome, Restriction Mapping, Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review